Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously
Clinical trial NCT02805010 · UNKNOWN
Trial details
- NCT number
- NCT02805010
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2017-02-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.